• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用下一代测序和实时定量聚合酶链反应鉴定子宫内膜异位症的候选 microRNA 标志物。

Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction.

机构信息

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

出版信息

Fertil Steril. 2020 Jun;113(6):1232-1241. doi: 10.1016/j.fertnstert.2020.01.026.

DOI:10.1016/j.fertnstert.2020.01.026
PMID:32482255
Abstract

OBJECTIVE

To identify novel candidate diagnostic microRNA (miRNA) markers of endometriosis by means of an unbiased search with confirmation by means of targeted polymerase chain reaction (PCR).

DESIGN

Retrospective cohort.

SETTING

University teaching hospitals.

PATIENT(S): Women with endometriosis and control women, confirmed with the use of laparoscopy.

INTERVENTIONS(S): Diagnostic laparoscopy and blood sample.

MAIN OUTCOME MEASURE(S): Next-generation sequencing (NGS) and quantitative real-time PCR (qRT-PCR).

RESULT(S): Candidate miRNAs differentially expressed in women with endometriosis compared with control women were identified by means of NGS and selected for qRT-PCR. Plasma samples from another cohort of women with surgically confirmed endometriosis (n = 53) and disease-free control women (n = 53) were checked for hemolysis using spectrophotometry and the ratio of miR-23a and miR-451 by means of qRT-PCR. MicroRNA signatures were quantified by means of qRT-PCR in hemolysis-free plasma samples of case subjects (n = 25) and control subjects (n = 28) with the use of miRcury LNA miRNA. Circulating levels of eight miRNAs (miR-199a-3p, miR-143-3p, miR-340-5p, let-7b-5p, miR-21-5p, miR-17-5p, miR-20a-5p, and miR-103a-3p) were significantly lower in case subjects compared to control subjects. The sensitivity and specificity for individual miRNAs ranged from 0.36 to 1.00 and from 0.43 to 1.00, respectively, but when combined produced sensitivity and specificity of 0.92 and 0.86 with positive (PPV) and (NPV) predictive values of 0.85 and 0.92, respectively. However, combination of five miRNAs (miR-17-5p, miR-20a-5p, miR-199a-3p, miR-143-3p, and let-7b-5p) produced sensitivity and specificity of 0.96 and 0.79 with PPV and NPV of 0.80 and 0.96, respectively.

CONCLUSION(S): We conclude that a panel of candidate miRNAs was comparable to laparoscopy in distinguishing between women with endometriosis and control women.

摘要

目的

通过无偏搜索并通过靶向聚合酶链反应(PCR)进行确认,鉴定子宫内膜异位症的新型候选诊断微小 RNA(miRNA)标志物。

设计

回顾性队列。

地点

大学教学医院。

患者

子宫内膜异位症患者和经腹腔镜证实的对照妇女。

干预措施

诊断腹腔镜检查和血液样本。

主要观察指标

下一代测序(NGS)和实时定量 PCR(qRT-PCR)。

结果

通过 NGS 鉴定出与对照妇女相比在子宫内膜异位症妇女中表达差异的候选 miRNA,并通过 qRT-PCR 进行选择。使用分光光度法检查另一批经手术证实的子宫内膜异位症(n = 53)和无疾病对照妇女(n = 53)的血浆样本是否溶血,并通过 qRT-PCR 检查 miR-23a 和 miR-451 的比值。使用 miRcury LNA miRNA 在无溶血的病例组(n = 25)和对照组(n = 28)血浆样本中定量 miRNA 特征通过 qRT-PCR 进行。与对照组相比,病例组中 8 种 miRNA(miR-199a-3p、miR-143-3p、miR-340-5p、let-7b-5p、miR-21-5p、miR-17-5p、miR-20a-5p 和 miR-103a-3p)的循环水平显着降低。单独 miRNA 的灵敏度和特异性范围为 0.36 至 1.00,分别为 0.43 至 1.00,但当组合使用时,敏感性和特异性为 0.92 和 0.86,阳性(PPV)和(NPV)预测值分别为 0.85 和 0.92。然而,当组合使用 5 种 miRNA(miR-17-5p、miR-20a-5p、miR-199a-3p、miR-143-3p 和 let-7b-5p)时,敏感性和特异性为 0.96 和 0.79,PPV 和 NPV 分别为 0.80 和 0.96。

结论

我们得出的结论是,一组候选 miRNA 与腹腔镜检查在区分子宫内膜异位症患者和对照妇女方面具有可比性。

相似文献

1
Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction.采用下一代测序和实时定量聚合酶链反应鉴定子宫内膜异位症的候选 microRNA 标志物。
Fertil Steril. 2020 Jun;113(6):1232-1241. doi: 10.1016/j.fertnstert.2020.01.026.
2
Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis.血清微小RNA作为子宫内膜异位症的诊断标志物:基于芯片的综合分析
Fertil Steril. 2016 Aug;106(2):402-9. doi: 10.1016/j.fertnstert.2016.04.013. Epub 2016 May 11.
3
Plasma miRNAs Display Limited Potential as Diagnostic Tools for Endometriosis.血浆 miRNA 作为子宫内膜异位症诊断工具的潜力有限。
J Clin Endocrinol Metab. 2019 Jun 1;104(6):1999-2022. doi: 10.1210/jc.2018-01464.
4
Accurate diagnosis of endometriosis using serum microRNAs.使用血清 microRNAs 进行子宫内膜异位症的准确诊断。
Am J Obstet Gynecol. 2020 Oct;223(4):557.e1-557.e11. doi: 10.1016/j.ajog.2020.02.050. Epub 2020 Mar 9.
5
Peripheral leukocyte microRNAs as novel biomarkers for COPD.外周血白细胞微小RNA作为慢性阻塞性肺疾病的新型生物标志物
Int J Chron Obstruct Pulmon Dis. 2017 Apr 6;12:1101-1112. doi: 10.2147/COPD.S130416. eCollection 2017.
6
Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.血浆 microRNA 谱作为鉴别成人Still 病与脓毒症的潜在生物标志物。
Front Immunol. 2019 Jan 11;9:3099. doi: 10.3389/fimmu.2018.03099. eCollection 2018.
7
Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.循环微小RNA作为口腔鳞状细胞癌手术患者复发的生物标志物
Oncotarget. 2017 Jan 31;8(5):8206-8214. doi: 10.18632/oncotarget.14143.
8
Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.鉴定血浆中的 7 个 microRNA 特征作为鼻咽癌检测有前途的生物标志物。
Cancer Med. 2020 Feb;9(3):1230-1241. doi: 10.1002/cam4.2676. Epub 2019 Dec 19.
9
A Panel of Plasma miRNAs 199b-3p, 224-5p and Let-7d-3p as Non-Invasive Diagnostic Biomarkers for Endometriosis.一组血浆 miRNA 199b-3p、224-5p 和 Let-7d-3p 作为子宫内膜异位症的非侵入性诊断生物标志物。
Reprod Sci. 2021 Apr;28(4):991-999. doi: 10.1007/s43032-020-00415-z. Epub 2021 Jan 4.
10
Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome.与可逆性脑血管收缩综合征相关的循环 microRNAs。
Ann Neurol. 2021 Mar;89(3):459-473. doi: 10.1002/ana.25965. Epub 2020 Dec 30.

引用本文的文献

1
Precision Therapeutic and Preventive Molecular Strategies for Endometriosis-Associated Infertility.子宫内膜异位症相关性不孕症的精准治疗与预防分子策略
Int J Mol Sci. 2025 Aug 9;26(16):7706. doi: 10.3390/ijms26167706.
2
Integrative Analysis of Differentially Expressed miRNAs and Noncoding RNA Networks Reveals Molecular Mechanisms Underlying Metritis in Postpartum Dairy Cows.差异表达miRNA与非编码RNA网络的综合分析揭示了产后奶牛子宫内膜炎的分子机制
Curr Issues Mol Biol. 2025 Aug 11;47(8):643. doi: 10.3390/cimb47080643.
3
Leveraging epigenetic aberrations in the pathogenesis of endometriosis: from DNA methylation to non-coding RNAs.
利用表观遗传异常在子宫内膜异位症发病机制中的作用:从DNA甲基化到非编码RNA
Front Genet. 2025 Jul 28;16:1597287. doi: 10.3389/fgene.2025.1597287. eCollection 2025.
4
miRNA in Endometriosis-A New Hope or an Illusion?子宫内膜异位症中的微小RNA——新希望还是幻想?
J Clin Med. 2025 Jul 8;14(14):4849. doi: 10.3390/jcm14144849.
5
Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review.靶向细胞凋亡用于子宫内膜异位症防治的天然植物代谢产物研究进展:一项系统综述
Front Pharmacol. 2025 Jul 9;16:1624569. doi: 10.3389/fphar.2025.1624569. eCollection 2025.
6
Role of Salivary MicroRNA as a Marker of Progesterone Resistance in Endometriosis: Preliminary Results from a Single-Institution Experience.唾液微小RNA作为子宫内膜异位症孕激素抵抗标志物的作用:单机构经验的初步结果
Biomolecules. 2025 Mar 27;15(4):493. doi: 10.3390/biom15040493.
7
MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility.微小RNA作为女性不孕症的生物标志物和治疗靶点
Int J Mol Sci. 2024 Dec 3;25(23):12979. doi: 10.3390/ijms252312979.
8
Crosstalk Between Oxidative Stress and Epigenetics: Unveiling New Biomarkers in Human Infertility.氧化应激与表观遗传学的相互作用:在人类不孕中揭示新的生物标志物。
Cells. 2024 Nov 7;13(22):1846. doi: 10.3390/cells13221846.
9
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis.循环血清微小RNA作为子宫内膜异位症的非侵入性诊断生物标志物
Biomedicines. 2024 Oct 19;12(10):2393. doi: 10.3390/biomedicines12102393.
10
Exploring the Role of MicroRNAs in Progesterone and Estrogen Receptor Expression in Endometriosis.探索微小RNA在子宫内膜异位症中孕酮和雌激素受体表达中的作用。
Biomedicines. 2024 Sep 28;12(10):2218. doi: 10.3390/biomedicines12102218.